Literature DB >> 10603023

The impact of extent of resection in the management of malignant gliomas of childhood.

J L Finlay1, J H Wisoff.   

Abstract

Radical surgical resection of newly diagnosed glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA) in children is the most powerful favorable predictor of outcome when followed by radiation therapy and chemotherapy. In the largest study of childhood malignant gliomas (Children's Cancer Group Study, CCG-945), which was conducted between 1985 and 1992, a radical surgical resection was defined as greater than 90% resection of tumor as seen on imaging studies, predominantly using MRI. Of note is that the training of the neurosurgeon (i.e. in pediatric versus adult neurosurgery) had a significant impact on the extent of surgical resection in patients enrolled on this study. In children with recurrent malignant glial tumors, radical surgical resection has been shown to predict a more favorable survival for children, both with GBM and AA, undergoing high-dose (marrow-ablative) chemotherapy with hematopoietic stem cell rescue. In these studies, radical surgical resection was defined as resection leaving less than 3 cm maximal diameter of enhancing tumor mass in place.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603023     DOI: 10.1007/s003810050471

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

1.  Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.

Authors:  Tae-Young Jung; Ji Yeoun Lee; Dong-Seok Kim; Hyeon Jin Park; Chae-Yong Kim; Young-Shin Ra; Mee-Jeong Lee; Seong-Ho Kim; Hee-Jo Baek; Il Han Kim; Kyung Duk Park; Seung-Ki Kim
Journal:  J Neurooncol       Date:  2014-11-04       Impact factor: 4.130

2.  [Surgical intervention in patients with malignant glioma].

Authors:  Herwig Kostron; Karl Rössler
Journal:  Wien Med Wochenschr       Date:  2006-06

3.  Use of a compact intraoperative low-field magnetic imager in pediatric neurosurgery.

Authors:  Amer F Samdani; Michael Schulder; Jeffrey E Catrambone; Peter W Carmel
Journal:  Childs Nerv Syst       Date:  2004-11-25       Impact factor: 1.475

Review 4.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

5.  Considering iatrogenic psychosis after malignant glioma resection.

Authors:  Ashish Harish Shah; Catherine E Gordon; Amade Bregy; Nirav Shah; Ricardo Jorge Komotar
Journal:  BMJ Case Rep       Date:  2014-04-23

Review 6.  Pilomyxoid astrocytoma: a review.

Authors:  Ricardo J Komotar; J Mocco; Benjamin S Carson; Michael E Sughrue; Brad E Zacharia; Alexander C Sisti; Peter D Canoll; Alexander G Khandji; Tarik Tihan; Peter C Burger; Jeffery N Bruce
Journal:  MedGenMed       Date:  2004-12-09

7.  Intraoperative MRI to guide the resection of primary supratentorial glioblastoma multiforme--a quantitative radiological analysis.

Authors:  Jens P Schneider; Christos Trantakis; Matthias Rubach; Thomas Schulz; Juergen Dietrich; Dirk Winkler; Christof Renner; Ralf Schober; Kathrin Geiger; Oana Brosteanu; Claus Zimmer; Thomas Kahn
Journal:  Neuroradiology       Date:  2005-06-11       Impact factor: 2.804

8.  Radical resection of focal brainstem gliomas: is it worth doing?

Authors:  Charles Teo; Timothy L Siu
Journal:  Childs Nerv Syst       Date:  2008-06-18       Impact factor: 1.475

9.  Pediatric giant cell glioblastoma: New insights into a rare tumor entity.

Authors:  Michael Karremann; Sandra Butenhoff; Ulrike Rausche; Torsten Pietsch; Johannes E A Wolff; Christof M Kramm
Journal:  Neuro Oncol       Date:  2008-12-02       Impact factor: 12.300

10.  Anaplastic ganglioglioma in children.

Authors:  Michael Karremann; Torsten Pietsch; Gisela Janssen; Christof M Kramm; Johannes E A Wolff
Journal:  J Neurooncol       Date:  2008-11-29       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.